Given that osteoclast plays a key role in bone remodeling, therapeutic methods or drugs, which focus on inhibiting the activity and differentiation of OC, are considered major treatment options for keeping or increasing the bone mass in osteoporosis patients [6, 7]. This evidence concerns the gene BGLAP and osteoporosis.